FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Hackenbruch, Christopher; Bauer, Jens; Heitmann, Jonas S.; Maringer, Yacine; Nelde, Annika; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Federmann, Birgit; Jung, Susanne; Martus, Peter; Malek, Nisar P.; Nikolaou, Konstantin; Salih, Helmut R.; Bitzer, Michael; Walz, Juliane S.

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Autor(en):

Hackenbruch, Christopher; Bauer, Jens; Heitmann, Jonas S.; Maringer, Yacine; Nelde, Annika; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Federmann, Birgit; Jung, Susanne; Martus, Peter; Malek, Nisar P.; Nikolaou, Konstantin; Salih, Helmut R.; Bitzer, Michael; Walz, Juliane S.

Tübinger Autor(en):